Trial Profile
A longitudinal pilot study assessing changes in cortical excitability in patients with relapsing-remitting MS (RRMS) following administration of FTY720 by using transcranial magnetic stimulation (TMS)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 Dec 2015 New trial record